These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22304337)

  • 1. Burden of breast cancer with brain metastasis: a French national hospital database analysis.
    Benjamin L; Cotté FE; Mercier F; Vainchtock A; Vidal-Trécan G; Durand-Zaleski I
    J Med Econ; 2012; 15(3):493-9. PubMed ID: 22304337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare cost attributable to recently-diagnosed breast cancer in a privately-insured population in the United States.
    Fu AZ; Jhaveri M
    J Med Econ; 2012; 15(4):688-94. PubMed ID: 22397589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
    Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
    Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of melanoma in France: assessing healthcare use in a hospital setting.
    Chevalier J; Bonastre J; Avril MF
    Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients.
    Wolstenholme V; Hawkins M; Ashley S; Tait D; Ross G
    Breast; 2008 Dec; 17(6):661-5. PubMed ID: 18571923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain metastases as late breast cancer relapse. Single institution experience and review of the literature.
    Tomasevic Z; Radosevic-Jelic Lj; Jovanovic D; Milovanovic Z; Tomasevic ZM; Jelic S; Borojevic N
    J BUON; 2009; 14(2):225-8. PubMed ID: 19650170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of metastatic breast cancer: a U.S. managed care perspective.
    Montero AJ; Eapen S; Gorin B; Adler P
    Breast Cancer Res Treat; 2012 Jul; 134(2):815-22. PubMed ID: 22684273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns in patients with advanced breast cancer who were exposed to an anthracycline, a taxane, and capecitabine: a descriptive report.
    Donato BM; Burns L; Willey V; Cohenuram M; Oliveria S; Yood MU
    Clin Ther; 2010 Mar; 32(3):546-54. PubMed ID: 20399992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the costs and resource use associated with adjuvant chemotherapy for breast cancer in France.
    Laas E; Vataire AL; Aballea S; Valentine W; Gligorov J; Chereau E; Rouzier R
    J Med Econ; 2012; 15(6):1167-75. PubMed ID: 22853442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan.
    Henk HJ; Kaura S
    J Med Econ; 2012; 15(1):175-84. PubMed ID: 22017235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
    Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
    Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
    Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
    Sanpaolo P; Barbieri V; Genovesi D
    Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary metastases of breast cancer. When is resection indicated?
    Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
    Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
    Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the economic burden of breast cancer in a US managed care population.
    Barron JJ; Quimbo R; Nikam PT; Amonkar MM
    Breast Cancer Res Treat; 2008 May; 109(2):367-77. PubMed ID: 17674201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of chronic low back pain with and without a neuropathic component: a healthcare resource use and cost analysis.
    Mehra M; Hill K; Nicholl D; Schadrack J
    J Med Econ; 2012; 15(2):245-52. PubMed ID: 22136441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.